Santangelo; Francesco

Patent Applications and Registrations

Patent applications and USPTO patent grants for Santangelo; Francesco.The latest application filed is for "use of cystine or cysteine for the prevention and treatment of oxidative stress cause by haemodialysis and of acute or chronic kidney diseases".

Company Profile

0.12.3

Santangelo; Francesco - Milan N/A IT
Santangelo; Francesco - Milano IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for treating hemodialysis-related oxidative stress using cystine or cysteine Grant 8,362,079 - Santangelo January 29, 2	2013-01-29
Use of Cystine or Cysteine for the Prevention and Treatment of Oxidative Stress Cause by Haemodialysis and of Acute or Chronic Kidney Diseases App 20070270495 - Santangelo; Francesco	2007-11-22
Phthalazine derivatives as phosphodiesterase 4-inhibitors App 20040043999 - Napoletano, Mauro ; et al.	2004-03-04
Methods of decreasing the effects of oxidative stress using N-acetylcysteine Grant 6,627,659 - Santangelo September 30, 2	2003-09-30
Use of N-acetylcysteine for the preparation of a medicament suitable for the intravenous administration to prevent oxidative stress in dialysed patients App 20030139472 - Santangelo, Francesco	2003-07-24
Phosphinic acid derivatives with metallopeptidase inhibitory activity Grant 5,739,123 - Norcini , et al. April 14, 1	1998-04-14
Compounds active on the cardiovascular system Grant 5,468,746 - Casagrande , et al. November 21, 1	1995-11-21
N-heteroaryl substituted derivatives of propanamide useful in the treatment of cardiovascular diseases Grant 5,438,046 - Norcini , et al. August 1, 1	1995-08-01
Diphosphates of catecholamines and pharmaceutical compositions containing them Grant 5,438,047 - Santangelo , et al. August 1, 1	1995-08-01
Compounds active as inhibitors of the cholesterol biosynthesis Grant 5,196,440 - Bertolini , et al. March 23, 1	1993-03-23
Dopamine pro-drug Grant 5,073,547 - Casagrande , et al. December 17, 1	1991-12-17
Pharmaceutically-active phthalazine compounds Grant 4,983,606 - Casagrande , et al. January 8, 1	1991-01-08
Beazimidazole compounds active as inhibitors of the cholesterol biosynthesis Grant 4,940,800 - Bertolini , et al. July 10, 1	1990-07-10
Biologically active peptides Grant 4,350,627 - de Castiglione , et al. September 21, 1	1982-09-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.